Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients

Semin Thromb Hemost. 2023 Feb;49(1):79-80. doi: 10.1055/s-0042-1756185. Epub 2022 Sep 2.

Authors

John G Rizk¹, Carl J Lavie², Brandon Michael Henry³

Affiliations

¹ Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, United States.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, United States.
³ Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.

PMID: 36055259
DOI: 10.1055/s-0042-1756185

No abstract available

MeSH terms

Anticoagulants / therapeutic use
Blood Coagulation
COVID-19*
Critical Illness
Humans
Retrospective Studies

Substances

Anticoagulants